ArticleMethods in molecular biology (Clifton, N.J.)2026
Experimental Validation of MicroRNA Targets: Mutagenesis of Binding Regions Mutagenesis-Based Validation of MicroRNA Target Binding.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are small, noncoding RNA molecules, typically 22 to 25 nucleotides long, that serve as critical regulators of gene expression at the post-transcriptional level. By binding to specific messenger RNAs (mRNAs), miRNAs can lead to translational repression or mRNA degradation, thereby modulating various cellular processes. While computational tools utilizing algorithmic models have been developed to predict miRNA-mRNA interactions, experimental validation remains essential. To ensure the reliability of these predictions, laboratory techniques have been continuously refined to enhance target verification accuracy. Among the established validation methods, the luciferase reporter assay is widely employed to evaluate miRNA-mRNA interactions. This approach involves a reporter plasmid containing the 3' untranslated region (UTR) of the target gene, enabling the assessment of miRNA-mediated regulation through alterations in luciferase activity. Introducing targeted mutations within the 3' UTR serves as a critical strategy to ascertain the specificity of miRNA binding by assessing changes in luciferase signal output. This chapter provides an in-depth overview of the experimental workflow for 3' UTR mutagenesis, emphasizing optimized protocols and best practices for integrating this technique into miRNA functional studies. Additionally, it highlights methodological refinements that improve the precision and reproducibility of luciferase assay-based target validation.
Indexed as
Identifiers
42681333What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.